Uncategorized

High Value – Physician Directed Weight Management

The New Year is here.  With it come the hopes, dreams and resolutions.  Weight loss remains at the top of many lists and 2012 will be no exception.  Many of us are able to adjust eating and exercise to achieve these goals.   Unfortunately, there are many who suffer from chronic obesity and require additional help to address their weight loss challenges.  Some qualify for bariatric surgery but many do not.  For the chronically obese who are not good candidates for surgery, prescription medications remain an important part of an overall program to address this disease.

There are many practices that specialize in physician-directed weight management.  Often, doctors choose to simplify the process by offering prepackaged medications from their office.  This saves patients the inconvenience of going to the pharmacy.  Clinic dispensing is legal in most states and physicians have been dispensing medications to patients for hundreds of years.

The primary dispensed medications for weight management are phentermine, phendimetrazine and diethylpropion.  These appetite suppressants are important parts of the process and can aid in weight reduction.  Physicians offering medication dispensing along with their medical consultations provide significant value to these patients.  Many patients are seeking support from their primary care providers and physicians are playing an increasingly important role in helping patients manage obesity.  Offering the right clinical pharmaceuticals gives the practice an edge in helping patients combat this disease.

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading